Mark M. Mendez

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Knowles Corporation of $150 million aggregate principal amount of its 3.25%…

Davis Polk advised Anacor Pharmaceuticals, Inc. in connection with its offering of $287.5 million aggregate principal amount of its 2.00% convertible senior notes due 2023 to qualified…

Davis Polk is advising Atairos on its $250 million investment in Groupon. Under the terms of the investment, Atairos is purchasing $250 million in aggregate principal amount of 3.25%…

Davis Polk acted as counsel to an affiliate of the counterparty in connection with the execution of a forward sale agreement with Regency Centers Corporation relating to 3,100,000 shares of…

Davis Polk is advising Markit on its all-share merger of equals with IHS valued at more than $13 billion. The transaction is expected to close in the second half of 2016, subject to…

Davis Polk advised the joint book-running managers on an SEC-registered offering by KKR & Co. L.P. of 13,800,000 6.75% Series A preferred units, which includes the full exercise of the…

Davis Polk advised the dealer manager in connection with a fixed-dollar, uncollared accelerated share repurchase transaction it entered into with Ulta Salon, Cosmetics & Fragrance, Inc…

Davis Polk advised the counterparty in connection with an accelerated share repurchase transaction entered into between the counterparty and Pfizer Inc. (“Pfizer”), pursuant to which Pfizer…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Invacare Corporation of $130 million aggregate principal amount of its 5.00%…

Davis Polk advised the representative of the several underwriters in connection with the $975 million SEC-registered offering of 25,000,000 shares of common stock of Hess Corporation, and…